Share with others who have ER-/PR-/HER2- breast cancer.
Posted on: Sep 22, 2021 01:01PM
Adding Carboplatin to Chemotherapy Before Surgery Improves Early-Stage Triple-Negative Breast Cancer Outcomes
September 20, 2021
Adding carboplatin (brand name: Paraplatin) to the standard neoadjuvant chemotherapy regimen for early-stage triple-negative breast cancer improved event-free survival. Read more...